Catherine Bennett
Nurse Practitioner · Port Orange, FLNPI 1356763676
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 73 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 19 manufacturers, the largest accounting for just 23.0% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $610 and has fallen 81.9% since, to $111 in 2025.
Across 73 payments — averaging $15.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$258
- Novo Nordisk$200
- Amgen$83
- Pfizer$64
- Amarin Pharma, Inc.$55
- Novartis$48
- plus $412 from 13 others
What the payments were for
- Food & beverage$1,121100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 19 | $258 |
| Novo Nordisk | 18 | $200 |
| Amgen | 4 | $83 |
| Pfizer | 3 | $64 |
| Amarin Pharma, Inc. | 3 | $55 |
| Novartis | 2 | $48 |
| Johnson & Johnson | 3 | $46 |
| AstraZeneca | 2 | $42 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $41 |
| Abbott | 2 | $40 |
| Lilly USA, LLC | 2 | $37 |
| Merck | 2 | $32 |
| Otsuka America Pharmaceutical, Inc. | 2 | $32 |
| GSK | 2 | $30 |
| Eisai Inc. | 2 | $30 |
| Boehringer Ingelheim | 2 | $29 |
| Biohaven Pharmaceuticals, Inc. | 1 | $23 |
| Jazz Pharmaceuticals Inc. | 1 | $19 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $12 |
How this compares
$1,121 in reported general payments places this provider in the 75th percentile of 8,290 nurse practitioner providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 42 | $45,849 |
| JardianceEmpagliflozin | 17 | $19,356 |
| Stiolto RespimatTiotropium Br/Olodaterol Hcl | 12 | $11,446 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 89 | $2,815 |
| Atorvastatin Calcium | 237 | $1,524 |
| Gabapentin | 95 | $1,433 |
| Levothyroxine Sodium | 109 | $910 |
| Losartan Potassium | 89 | $732 |
| Pantoprazole Sodium | 43 | $641 |
| Omeprazole | 83 | $579 |
| Lisinopril | 132 | $547 |
| Amlodipine Besylate | 190 | $535 |
| Duloxetine Hcl | 29 | $482 |
| Metoprolol Succinate | 48 | $466 |
| Rosuvastatin Calcium | 60 | $449 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $64 | $45,84942 claims |
| Boehringer IngelheimJardiance, Stiolto Respimat | $29 | $30,80129 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 8,290 nurse practitioner providers in Florida.
Other nurse practitioner in Port Orange
- Jolanta BaginskiClearwater$494K
- Adissa PerezWinter Park$370K
- April WessonTampa$342K
- Margarita FernandezMiami$311K
- Stephanie SimmermanNaples$283K
- Claudette WalkerPonte Vedra Beach$271K
- Lisa NodzonTampa$246K
- Ashima BahlTampa$226K
- Maya BloombergMiami$202K
- Jennifer PuleoTampa$171K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.